APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nausea And Vomiting Treatment

Nausea and Vomiting Treatment also called Antiemetics. Antiemetics included aprepitant, diphenhydramine, granisetron, hydroxyzine, meclizine, ondansetron, prochlorperazine, promethazine, scopolamine, metoclopramide, trimethobenzamide, palonosetron, dolasetron, and thiethylperazine, etc.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Nausea and Vomiting Treatment also called Antiemetics. Antiemetics included aprepitant, diphenhydramine, granisetron, hydroxyzine, meclizine, ondansetron, prochlorperazine, promethazine, scopolamine, metoclopramide, trimethobenzamide, palonosetron, dolasetron, and thiethylperazine, etc.

Selected research

Market Structure

Global Nausea And Vomiting Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025196 pages

Choose your research edition.

Industry ResearchNausea And Vomiting Treatment Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Nausea And Vomiting Treatment Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Nausea And Vomiting Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nausea And Vomiting Treatment Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Nausea And Vomiting Treatment Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

Nausea and Vomiting Treatment also called Antiemetics. Antiemetics included aprepitant, diphenhydramine, granisetron, hydroxyzine, meclizine, ondansetron, prochlorperazine, promethazine, scopolamine, metoclopramide, trimethobenzamide, palonosetron, dolasetron, and thiethylperazine, etc.

United States is the largest Nausea And Vomiting Treatment market with about 42% market share. Europe is follower, accounting for about 20% market share.Merck & Co. Inc. was the global greatest company in Nausea And Vomiting Treatment industry, with the market Share of 14% , followed by Helsinn Group, Unimed Pharmaceuticals (AbbVie Inc.), Kyowa Kirin, Sanofi, Qilu Pharma, Teva Pharmaceutical Industries Ltd., Taiji group, Novartis, Heron Therapeutics, Atnahs Pharma UK Limited, Mylan, Duchesnay, Tesaro.

Report Includes

Read the full market overview

This report provides an overview of the global Nausea And Vomiting Treatment market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nausea And Vomiting Treatment and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nausea And Vomiting Treatment revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Nausea And Vomiting Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Nausea And Vomiting Treatment Segment by Company

Merck & Co. Inc.

Helsinn Group

Unimed Pharmaceuticals (AbbVie Inc.)

Kyowa Kirin

Sanofi

Qilu Pharma

Teva Pharmaceutical Industries Ltd.

Taiji group

Novartis

Heron Therapeutics

Atnahs Pharma UK Limited

Mylan

Duchesnay

Tesaro

Nausea And Vomiting Treatment Segment by Type

Serotonin Receptor Antagonist

Neurokinin NK1 Receptor Antagonist

Others

Nausea And Vomiting Treatment Segment by Application

CINV

PONV

Motion Sickness

Pregnancy

Others

Nausea And Vomiting Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nausea And Vomiting Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nausea And Vomiting Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nausea And Vomiting Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Nausea And Vomiting Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nausea And Vomiting Treatment industry.

Chapter 3: Detailed analysis of Nausea And Vomiting Treatment companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nausea And Vomiting Treatmentrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Nausea And Vomiting Treatment Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Serotonin Receptor Antagonist Table 3. Key Players of Neurokinin NK1 Receptor Antagonist Table 4. Key Players of Others Table 4. Global Nausea And Vomiting Treatment Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of CINV Table 6. Key Players of PONV Table 7. Key Players of Motion Sickness Table 8. Key Players of Pregnancy Table 9. Key Players of Others Table 10. Global Nausea And Vomiting Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Nausea And Vomiting Treatment Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Nausea And Vomiting Treatment Market Share by Region (2021-2026) Table 13. Global Nausea And Vomiting Treatment Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Nausea And Vomiting Treatment Market Share by Region (2027-2032) Table 15. Nausea And Vomiting Treatment Industry Trends Table 16. Nausea And Vomiting Treatment Industry Drivers Table 17. Nausea And Vomiting Treatment Industry Opportunities and Challenges Table 18. Nausea And Vomiting Treatment Industry Restraints Table 19. Global Nausea And Vomiting Treatment Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Nausea And Vomiting Treatment Revenue Market Share by Company (2021-2026) Table 21. Global Nausea And Vomiting Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Nausea And Vomiting Treatment Key Company Head Office and Area Served Table 23. Global Nausea And Vomiting Treatment Company, Product Type & Application Table 24. Global Nausea And Vomiting Treatment Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Nausea And Vomiting Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Nausea And Vomiting Treatment Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Nausea And Vomiting Treatment Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Nausea And Vomiting Treatment Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Nausea And Vomiting Treatment Revenue Market Share by Type (2021-2026) Table 31. Global Nausea And Vomiting Treatment Revenue Market Share by Type (2027-2032) Table 32. Global Nausea And Vomiting Treatment Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Nausea And Vomiting Treatment Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Nausea And Vomiting Treatment Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Nausea And Vomiting Treatment Revenue Market Share by Application (2021-2026) Table 36. Global Nausea And Vomiting Treatment Revenue Market Share by Application (2027-2032) Table 37. Merck & Co. Inc. Company Information Table 38. Merck & Co. Inc. Business Overview Table 39. Merck & Co. Inc. Nausea And Vomiting Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Merck & Co. Inc. Nausea And Vomiting Treatment Product Portfolio Table 41. Merck & Co. Inc. Recent Development Table 42. Helsinn Group Company Information Table 43. Helsinn Group Business Overview Table 44. Helsinn Group Nausea And Vomiting Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Helsinn Group Nausea And Vomiting Treatment Product Portfolio Table 46. Helsinn Group Recent Development Table 47. Unimed Pharmaceuticals (AbbVie Inc.) Company Information Table 48. Unimed Pharmaceuticals (AbbVie Inc.) Business Overview Table 49. Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Product Portfolio Table 51. Unimed Pharmaceuticals (AbbVie Inc.) Recent Development Table 52. Kyowa Kirin Company Information Table 53. Kyowa Kirin Business Overview Table 54. Kyowa Kirin Nausea And Vomiting Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Kyowa Kirin Nausea And Vomiting Treatment Product Portfolio Table 56. Kyowa Kirin Recent Development Table 57. Sanofi Company Information Table 58. Sanofi Business Overview Table 59. Sanofi Nausea And Vomiting Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Sanofi Nausea And Vomiting Treatment Product Portfolio Table 61. Sanofi Recent Development Table 62. Qilu Pharma Company Information Table 63. Qilu Pharma Business Overview Table 64. Qilu Pharma Nausea And Vomiting Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Qilu Pharma Nausea And Vomiting Treatment Product Portfolio Table 66. Qilu Pharma Recent Development Table 67. Teva Pharmaceutical Industries Ltd. Company Information Table 68. Teva Pharmaceutical Industries Ltd. Business Overview Table 69. Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Product Portfolio Table 71. Teva Pharmaceutical Industries Ltd. Recent Development Table 72. Taiji group Company Information Table 73. Taiji group Business Overview Table 74. Taiji group Nausea And Vomiting Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Taiji group Nausea And Vomiting Treatment Product Portfolio Table 76. Taiji group Recent Development Table 77. Novartis Company Information Table 78. Novartis Business Overview Table 79. Novartis Nausea And Vomiting Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Novartis Nausea And Vomiting Treatment Product Portfolio Table 81. Novartis Recent Development Table 82. Heron Therapeutics Company Information Table 83. Heron Therapeutics Business Overview Table 84. Heron Therapeutics Nausea And Vomiting Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Heron Therapeutics Nausea And Vomiting Treatment Product Portfolio Table 86. Heron Therapeutics Recent Development Table 87. Atnahs Pharma UK Limited Company Information Table 88. Atnahs Pharma UK Limited Business Overview Table 89. Atnahs Pharma UK Limited Nausea And Vomiting Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 90. Atnahs Pharma UK Limited Nausea And Vomiting Treatment Product Portfolio Table 91. Atnahs Pharma UK Limited Recent Development Table 92. Mylan Company Information Table 93. Mylan Business Overview Table 94. Mylan Nausea And Vomiting Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 95. Mylan Nausea And Vomiting Treatment Product Portfolio Table 96. Mylan Recent Development Table 97. Duchesnay Company Information Table 98. Duchesnay Business Overview Table 99. Duchesnay Nausea And Vomiting Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 100. Duchesnay Nausea And Vomiting Treatment Product Portfolio Table 101. Duchesnay Recent Development Table 102. Tesaro Company Information Table 103. Tesaro Business Overview Table 104. Tesaro Nausea And Vomiting Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 105. Tesaro Nausea And Vomiting Treatment Product Portfolio Table 106. Tesaro Recent Development Table 107. North America Nausea And Vomiting Treatment Market Size by Type (2021-2026) & (US$ Million) Table 108. North America Nausea And Vomiting Treatment Market Size by Type (2027-2032) & (US$ Million) Table 109. North America Nausea And Vomiting Treatment Market Size by Application (2021-2026) & (US$ Million) Table 110. North America Nausea And Vomiting Treatment Market Size by Application (2027-2032) & (US$ Million) Table 111. North America Nausea And Vomiting Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. North America Nausea And Vomiting Treatment Market Size by Country (2021-2026) Table 113. North America Nausea And Vomiting Treatment Market Size by Country (2027-2032) Table 114. Europe Nausea And Vomiting Treatment Market Size by Type (2021-2026) & (US$ Million) Table 115. Europe Nausea And Vomiting Treatment Market Size by Type (2027-2032) & (US$ Million) Table 116. Europe Nausea And Vomiting Treatment Market Size by Application (2021-2026) & (US$ Million) Table 117. Europe Nausea And Vomiting Treatment Market Size by Application (2027-2032) & (US$ Million) Table 118. Europe Nausea And Vomiting Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. Europe Nausea And Vomiting Treatment Market Size by Country (2021-2026) Table 120. Europe Nausea And Vomiting Treatment Market Size by Country (2027-2032) Table 121. China Nausea And Vomiting Treatment Market Size by Type (2021-2026) & (US$ Million) Table 122. China Nausea And Vomiting Treatment Market Size by Type (2027-2032) & (US$ Million) Table 123. China Nausea And Vomiting Treatment Market Size by Application (2021-2026) & (US$ Million) Table 124. China Nausea And Vomiting Treatment Market Size by Application (2027-2032) & (US$ Million) Table 125. Asia Nausea And Vomiting Treatment Market Size by Type (2021-2026) & (US$ Million) Table 126. Asia Nausea And Vomiting Treatment Market Size by Type (2027-2032) & (US$ Million) Table 127. Asia Nausea And Vomiting Treatment Market Size by Application (2021-2026) & (US$ Million) Table 128. Asia Nausea And Vomiting Treatment Market Size by Application (2027-2032) & (US$ Million) Table 129. Asia Nausea And Vomiting Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. Asia Nausea And Vomiting Treatment Market Size by Country (2021-2026) Table 131. Asia Nausea And Vomiting Treatment Market Size by Country (2027-2032) Table 132. South America, Middle East & Africa Nausea And Vomiting Treatment Market Size by Type (2021-2026) & (US$ Million) Table 133. South America, Middle East & Africa Nausea And Vomiting Treatment Market Size by Type (2027-2032) & (US$ Million) Table 134. South America, Middle East & Africa Nausea And Vomiting Treatment Market Size by Application (2021-2026) & (US$ Million) Table 135. South America, Middle East & Africa Nausea And Vomiting Treatment Market Size by Application (2027-2032) & (US$ Million) Table 136. South America, Middle East & Africa Nausea And Vomiting Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. South America, Middle East & Africa Nausea And Vomiting Treatment Market Size by Country (2021-2026) Table 138. South America, Middle East & Africa Nausea And Vomiting Treatment Market Size by Country (2027-2032) Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. Nausea And Vomiting Treatment Product Image Figure 2. Global Nausea And Vomiting Treatment Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Nausea And Vomiting Treatment Market Share by Type: 2025 VS 2032 Figure 4. Serotonin Receptor Antagonist Image Figure 5. Neurokinin NK1 Receptor Antagonist Image Figure 6. Others Image Figure 7. Global Nausea And Vomiting Treatment Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Nausea And Vomiting Treatment Market Share by Application: 2025 VS 2032 Figure 9. CINV Image Figure 10. PONV Image Figure 11. Motion Sickness Image Figure 12. Pregnancy Image Figure 13. Others Image Figure 14. Global Nausea And Vomiting Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Nausea And Vomiting Treatment Market Size (2021-2032) & (US$ Million) Figure 16. Global Nausea And Vomiting Treatment Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Nausea And Vomiting Treatment Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Nausea And Vomiting Treatment Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Nausea And Vomiting Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Nausea And Vomiting Treatment Revenue Market Share by Type (2021-2032) Figure 23. Global Nausea And Vomiting Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Nausea And Vomiting Treatment Revenue Market Share by Application (2021-2032) Figure 25. North America Nausea And Vomiting Treatment Market Size (2021-2032) & (US$ Million) Figure 26. North America Nausea And Vomiting Treatment Market Share by Type (2021-2032) Figure 27. North America Nausea And Vomiting Treatment Market Share by Application (2021-2032) Figure 28. North America Nausea And Vomiting Treatment Market Share by Country (2021-2032) Figure 29. United States Nausea And Vomiting Treatment Market Size (2021-2032) & (US$ Million) Figure 30. Canada Nausea And Vomiting Treatment Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Nausea And Vomiting Treatment Market Size (2021-2032) & (US$ Million) Figure 32. Europe Nausea And Vomiting Treatment Market Size (2021-2032) & (US$ Million) Figure 33. Europe Nausea And Vomiting Treatment Market Share by Type (2021-2032) Figure 34. Europe Nausea And Vomiting Treatment Market Share by Application (2021-2032) Figure 35. Europe Nausea And Vomiting Treatment Market Share by Country (2021-2032) Figure 36. Germany Nausea And Vomiting Treatment Market Size (2021-2032) & (US$ Million) Figure 37. France Nausea And Vomiting Treatment Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Nausea And Vomiting Treatment Market Size (2021-2032) & (US$ Million) Figure 39. Italy Nausea And Vomiting Treatment Market Size (2021-2032) & (US$ Million) Figure 40. Russia Nausea And Vomiting Treatment Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Nausea And Vomiting Treatment Market Size (2021-2032) & (US$ Million) Figure 42. China Nausea And Vomiting Treatment Market Size (2021-2032) & (US$ Million) Figure 43. China Nausea And Vomiting Treatment Market Share by Type (2021-2032) Figure 44. China Nausea And Vomiting Treatment Market Share by Application (2021-2032) Figure 45. Asia Nausea And Vomiting Treatment Market Size (2021-2032) & (US$ Million) Figure 46. Asia Nausea And Vomiting Treatment Market Share by Type (2021-2032) Figure 47. Asia Nausea And Vomiting Treatment Market Share by Application (2021-2032) Figure 48. Asia Nausea And Vomiting Treatment Market Share by Country (2021-2032) Figure 49. Japan Nausea And Vomiting Treatment Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Nausea And Vomiting Treatment Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Nausea And Vomiting Treatment Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Nausea And Vomiting Treatment Market Size (2021-2032) & (US$ Million) Figure 53. India Nausea And Vomiting Treatment Market Size (2021-2032) & (US$ Million) Figure 54. Australia Nausea And Vomiting Treatment Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Nausea And Vomiting Treatment Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Nausea And Vomiting Treatment Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Nausea And Vomiting Treatment Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Nausea And Vomiting Treatment Market Share by Country (2021-2032) Figure 59. Brazil Nausea And Vomiting Treatment Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Nausea And Vomiting Treatment Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Nausea And Vomiting Treatment Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Nausea And Vomiting Treatment Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Nausea And Vomiting Treatment Market Size (2021-2032) & (US$ Million) Figure 64. UAE Nausea And Vomiting Treatment Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Nausea And Vomiting Treatment Market Size (2021-2032) & (US$ Million) Figure 66. Chile Nausea And Vomiting Treatment Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • Serotonin Receptor Antagonist
  • Neurokinin NK1 Receptor Antagonist
  • Others
Applications
  • CINV
  • PONV
  • Motion Sickness
  • Pregnancy
  • Others
Companies covered
  • Merck & Co. Inc.
  • Helsinn Group
  • Unimed Pharmaceuticals (AbbVie Inc.)
  • Kyowa Kirin
  • Sanofi
  • Qilu Pharma
  • Teva Pharmaceutical Industries Ltd.
  • Taiji group
  • Novartis
  • Heron Therapeutics
  • Atnahs Pharma UK Limited
  • Mylan
  • Duchesnay
  • Tesaro

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Nausea And Vomiting Treatment Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Serotonin Receptor Antagonist
  5. 1.2.3 Neurokinin NK1 Receptor Antagonist
  6. 1.2.4 Others
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Nausea And Vomiting Treatment Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 CINV
  10. 1.3.3 PONV
  11. 1.3.4 Motion Sickness
  12. 1.3.5 Pregnancy
  13. 1.3.6 Others
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Nausea And Vomiting Treatment Growth Trends by Region
  16. 1.5.1 Global Nausea And Vomiting Treatment Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Nausea And Vomiting Treatment Market Size by Region (2021-2026)
  18. 1.5.3 Nausea And Vomiting Treatment Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Nausea And Vomiting Treatment Market Dynamics
  1. 2.1 Nausea And Vomiting Treatment Industry Trends
  2. 2.2 Nausea And Vomiting Treatment Industry Drivers
  3. 2.3 Nausea And Vomiting Treatment Industry Opportunities and Challenges
  4. 2.4 Nausea And Vomiting Treatment Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Nausea And Vomiting Treatment Revenue by Company (2021-2026)
  2. 3.2 Global Nausea And Vomiting Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Nausea And Vomiting Treatment Key Company Head office and Area Served
  4. 3.4 Global Nausea And Vomiting Treatment Company, Product Type & Application
  5. 3.5 Global Nausea And Vomiting Treatment Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Nausea And Vomiting Treatment Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Nausea And Vomiting Treatment Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Nausea And Vomiting Treatment Tier 1, Tier 2, and Tier 3
4 Nausea And Vomiting Treatment Market by Type
  1. 4.1 Global Nausea And Vomiting Treatment Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Nausea And Vomiting Treatment Market Size by Type (2021-2032)
  3. 4.3 Global Nausea And Vomiting Treatment Market Size Share by Type (2021-2032)
5 Nausea And Vomiting Treatment Market by Application
  1. 5.1 Global Nausea And Vomiting Treatment Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Nausea And Vomiting Treatment Market Size by Application (2021-2032)
  3. 5.3 Global Nausea And Vomiting Treatment Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Merck & Co. Inc.
  2. 6.1.1 Merck & Co. Inc. Company Information
  3. 6.1.2 Merck & Co. Inc. Business Overview
  4. 6.1.3 Merck & Co. Inc. Nausea And Vomiting Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Merck & Co. Inc. Nausea And Vomiting Treatment Product Portfolio
  6. 6.1.5 Merck & Co. Inc. Recent Developments
  7. 6.2 Helsinn Group
  8. 6.2.1 Helsinn Group Company Information
  9. 6.2.2 Helsinn Group Business Overview
  10. 6.2.3 Helsinn Group Nausea And Vomiting Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Helsinn Group Nausea And Vomiting Treatment Product Portfolio
  12. 6.2.5 Helsinn Group Recent Developments
  13. 6.3 Unimed Pharmaceuticals (AbbVie Inc.)
  14. 6.3.1 Unimed Pharmaceuticals (AbbVie Inc.) Company Information
  15. 6.3.2 Unimed Pharmaceuticals (AbbVie Inc.) Business Overview
  16. 6.3.3 Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Product Portfolio
  18. 6.3.5 Unimed Pharmaceuticals (AbbVie Inc.) Recent Developments
  19. 6.4 Kyowa Kirin
  20. 6.4.1 Kyowa Kirin Company Information
  21. 6.4.2 Kyowa Kirin Business Overview
  22. 6.4.3 Kyowa Kirin Nausea And Vomiting Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Kyowa Kirin Nausea And Vomiting Treatment Product Portfolio
  24. 6.4.5 Kyowa Kirin Recent Developments
  25. 6.5 Sanofi
  26. 6.5.1 Sanofi Company Information
  27. 6.5.2 Sanofi Business Overview
  28. 6.5.3 Sanofi Nausea And Vomiting Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Sanofi Nausea And Vomiting Treatment Product Portfolio
  30. 6.5.5 Sanofi Recent Developments
  31. 6.6 Qilu Pharma
  32. 6.6.1 Qilu Pharma Company Information
  33. 6.6.2 Qilu Pharma Business Overview
  34. 6.6.3 Qilu Pharma Nausea And Vomiting Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Qilu Pharma Nausea And Vomiting Treatment Product Portfolio
  36. 6.6.5 Qilu Pharma Recent Developments
  37. 6.7 Teva Pharmaceutical Industries Ltd.
  38. 6.7.1 Teva Pharmaceutical Industries Ltd. Company Information
  39. 6.7.2 Teva Pharmaceutical Industries Ltd. Business Overview
  40. 6.7.3 Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Product Portfolio
  42. 6.7.5 Teva Pharmaceutical Industries Ltd. Recent Developments
  43. 6.8 Taiji group
  44. 6.8.1 Taiji group Company Information
  45. 6.8.2 Taiji group Business Overview
  46. 6.8.3 Taiji group Nausea And Vomiting Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Taiji group Nausea And Vomiting Treatment Product Portfolio
  48. 6.8.5 Taiji group Recent Developments
  49. 6.9 Novartis
  50. 6.9.1 Novartis Company Information
  51. 6.9.2 Novartis Business Overview
  52. 6.9.3 Novartis Nausea And Vomiting Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Novartis Nausea And Vomiting Treatment Product Portfolio
  54. 6.9.5 Novartis Recent Developments
  55. 6.10 Heron Therapeutics
  56. 6.10.1 Heron Therapeutics Company Information
  57. 6.10.2 Heron Therapeutics Business Overview
  58. 6.10.3 Heron Therapeutics Nausea And Vomiting Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Heron Therapeutics Nausea And Vomiting Treatment Product Portfolio
  60. 6.10.5 Heron Therapeutics Recent Developments
  61. 6.11 Atnahs Pharma UK Limited
  62. 6.11.1 Atnahs Pharma UK Limited Company Information
  63. 6.11.2 Atnahs Pharma UK Limited Business Overview
  64. 6.11.3 Atnahs Pharma UK Limited Nausea And Vomiting Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Atnahs Pharma UK Limited Nausea And Vomiting Treatment Product Portfolio
  66. 6.11.5 Atnahs Pharma UK Limited Recent Developments
  67. 6.12 Mylan
  68. 6.12.1 Mylan Company Information
  69. 6.12.2 Mylan Business Overview
  70. 6.12.3 Mylan Nausea And Vomiting Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Mylan Nausea And Vomiting Treatment Product Portfolio
  72. 6.12.5 Mylan Recent Developments
  73. 6.13 Duchesnay
  74. 6.13.1 Duchesnay Company Information
  75. 6.13.2 Duchesnay Business Overview
  76. 6.13.3 Duchesnay Nausea And Vomiting Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Duchesnay Nausea And Vomiting Treatment Product Portfolio
  78. 6.13.5 Duchesnay Recent Developments
  79. 6.14 Tesaro
  80. 6.14.1 Tesaro Company Information
  81. 6.14.2 Tesaro Business Overview
  82. 6.14.3 Tesaro Nausea And Vomiting Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Tesaro Nausea And Vomiting Treatment Product Portfolio
  84. 6.14.5 Tesaro Recent Developments
7 North America
  1. 7.1 North America Nausea And Vomiting Treatment Market Size (2021-2032)
  2. 7.2 North America Nausea And Vomiting Treatment Market Size by Type
  3. 7.2.1 North America Nausea And Vomiting Treatment Market Size by Type (2021-2026)
  4. 7.2.2 North America Nausea And Vomiting Treatment Market Size by Type (2027-2032)
  5. 7.2.3 North America Nausea And Vomiting Treatment Market Share by Type (2021-2032)
  6. 7.3 North America Nausea And Vomiting Treatment Market Size by Application
  7. 7.3.1 North America Nausea And Vomiting Treatment Market Size by Application (2021-2026)
  8. 7.3.2 North America Nausea And Vomiting Treatment Market Size by Application (2027-2032)
  9. 7.3.3 North America Nausea And Vomiting Treatment Market Share by Application (2021-2032)
  10. 7.4 North America Nausea And Vomiting Treatment Market Size by Country
  11. 7.4.1 North America Nausea And Vomiting Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Nausea And Vomiting Treatment Market Size by Country (2021-2026)
  13. 7.4.3 North America Nausea And Vomiting Treatment Market Size by Country (2027-2032)
  14. 7.4.4 North America Nausea And Vomiting Treatment Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Nausea And Vomiting Treatment Market Size (2021-2032)
  2. 8.2 Europe Nausea And Vomiting Treatment Market Size by Type
  3. 8.2.1 Europe Nausea And Vomiting Treatment Market Size by Type (2021-2026)
  4. 8.2.2 Europe Nausea And Vomiting Treatment Market Size by Type (2027-2032)
  5. 8.2.3 Europe Nausea And Vomiting Treatment Market Share by Type (2021-2032)
  6. 8.3 Europe Nausea And Vomiting Treatment Market Size by Application
  7. 8.3.1 Europe Nausea And Vomiting Treatment Market Size by Application (2021-2026)
  8. 8.3.2 Europe Nausea And Vomiting Treatment Market Size by Application (2027-2032)
  9. 8.3.3 Europe Nausea And Vomiting Treatment Market Share by Application (2021-2032)
  10. 8.4 Europe Nausea And Vomiting Treatment Market Size by Country
  11. 8.4.1 Europe Nausea And Vomiting Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Nausea And Vomiting Treatment Market Size by Country (2021-2026)
  13. 8.4.3 Europe Nausea And Vomiting Treatment Market Size by Country (2027-2032)
  14. 8.4.4 Europe Nausea And Vomiting Treatment Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Nausea And Vomiting Treatment Market Size (2021-2032)
  2. 9.2 China Nausea And Vomiting Treatment Market Size by Type
  3. 9.2.1 China Nausea And Vomiting Treatment Market Size by Type (2021-2026)
  4. 9.2.2 China Nausea And Vomiting Treatment Market Size by Type (2027-2032)
  5. 9.2.3 China Nausea And Vomiting Treatment Market Share by Type (2021-2032)
  6. 9.3 China Nausea And Vomiting Treatment Market Size by Application
  7. 9.3.1 China Nausea And Vomiting Treatment Market Size by Application (2021-2026)
  8. 9.3.2 China Nausea And Vomiting Treatment Market Size by Application (2027-2032)
  9. 9.3.3 China Nausea And Vomiting Treatment Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Nausea And Vomiting Treatment Market Size (2021-2032)
  2. 10.2 Asia Nausea And Vomiting Treatment Market Size by Type
  3. 10.2.1 Asia Nausea And Vomiting Treatment Market Size by Type (2021-2026)
  4. 10.2.2 Asia Nausea And Vomiting Treatment Market Size by Type (2027-2032)
  5. 10.2.3 Asia Nausea And Vomiting Treatment Market Share by Type (2021-2032)
  6. 10.3 Asia Nausea And Vomiting Treatment Market Size by Application
  7. 10.3.1 Asia Nausea And Vomiting Treatment Market Size by Application (2021-2026)
  8. 10.3.2 Asia Nausea And Vomiting Treatment Market Size by Application (2027-2032)
  9. 10.3.3 Asia Nausea And Vomiting Treatment Market Share by Application (2021-2032)
  10. 10.4 Asia Nausea And Vomiting Treatment Market Size by Country
  11. 10.4.1 Asia Nausea And Vomiting Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Nausea And Vomiting Treatment Market Size by Country (2021-2026)
  13. 10.4.3 Asia Nausea And Vomiting Treatment Market Size by Country (2027-2032)
  14. 10.4.4 Asia Nausea And Vomiting Treatment Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Nausea And Vomiting Treatment Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Nausea And Vomiting Treatment Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Nausea And Vomiting Treatment Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Nausea And Vomiting Treatment Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Nausea And Vomiting Treatment Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Nausea And Vomiting Treatment Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Nausea And Vomiting Treatment Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Nausea And Vomiting Treatment Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Nausea And Vomiting Treatment Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Nausea And Vomiting Treatment Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Nausea And Vomiting Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Nausea And Vomiting Treatment Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Nausea And Vomiting Treatment Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Nausea And Vomiting Treatment Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst